[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Mushtaq et al., 2021 - Google Patents

Exploiting Dengue Virus Protease as a Therapeutic Target: Current Status, Challenges and Future Avenues

Mushtaq et al., 2021

View PDF
Document ID
6864334858112445705
Author
Mushtaq M
Naz S
Parang K
Ul-Haq Z
Publication year
Publication venue
Current Medicinal Chemistry

External Links

Snippet

Dengue, the oldest and the most prevalent mosquito-borne illness, is caused by the dengue virus (DENV), from the family of Flaviviridae. It infects approximately 400 million individuals per annum, with approximately half of the global population residing in high-risk areas. The …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense
    • C12N2770/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense ssRNA Viruses positive-sense
    • C12N2770/24011—Flaviviridae

Similar Documents

Publication Publication Date Title
Nitsche et al. Biochemistry and medicinal chemistry of the dengue virus protease
Steuten et al. Challenges for targeting SARS-CoV-2 proteases as a therapeutic strategy for COVID-19
Chew et al. Peptides as therapeutic agents for dengue virus
CN102006865B (en) Use of chemical compounds in preparing pharmaceutical composition for attenuating or inhibiting virus infection of flaviviruses
Oliveira et al. The flavivirus capsid protein: Structure, function and perspectives towards drug design
Hill et al. The unique cofactor region of Zika virus NS2B–NS3 protease facilitates cleavage of key host proteins
Hariono et al. Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling
Xu et al. Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease
Rothan et al. Protegrin‐1 Inhibits Dengue NS2B‐NS3 Serine Protease and Viral Replication in MK2 Cells
Kampmann et al. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses
Timiri et al. Progress and prospects on DENV protease inhibitors
Brecher et al. The flavivirus protease as a target for drug discovery
Zu et al. Peptide inhibitor of Japanese encephalitis virus infection targeting envelope protein domain III
Lim et al. West Nile virus drug discovery
Xu et al. Design, synthesis, and biological evaluation of substituted 4, 6-dihydrospiro [[1, 2, 3] triazolo [4, 5-b] pyridine-7, 3′-indoline]-2′, 5 (3 H)-dione analogues as potent NS4B inhibitors for the treatment of dengue virus infection
Halim et al. Targeting dengue virus NS-3 helicase by ligand based pharmacophore modeling and structure based virtual screening
JP2009524581A (en) Methods and proteins for prophylactic and / or therapeutic treatment of four serotypes of dengue virus and other flaviviruses
Li et al. Flavivirus NS2B/NS3 protease: Structure, function, and inhibition
Chen et al. Benzenesulfonamide derivatives as calcium/calmodulin-dependent protein kinase inhibitors and antiviral agents against dengue and zika virus infections
Hu et al. Systematic analysis of structure similarity between Zika virus and other flaviviruses
Sinigaglia et al. New avenues for therapeutic discovery against West Nile virus
Mushtaq et al. Exploiting Dengue Virus Protease as a Therapeutic Target: Current Status, Challenges and Future Avenues
Baharuddin et al. Current approaches in antiviral drug discovery against the Flaviviridae family
Li et al. Dengue virus NS4B protein as a target for developing antivirals
Yevsieieva et al. Main and papain-like proteases as prospective targets for pharmacological treatment of coronavirus SARS-CoV-2